Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Anodal tDCS and Virtual Reality on Cognitive Dysfunction in Patients With Multiple Sclerosis: a Protocol of a Double Blind, Randomized, Prospective, Controlled Study.

NCT07114809 is registered in ClinicalTrials.gov with Ospedale Policlinico San Martino as lead sponsor.

NCT NCT07114809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07114809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Anodal tDCS and Virtual Reality on Cognitive Dysfunction in Patients With Multiple Sclerosis: a Protocol of a Double Blind, Randomized, Prospective, Controlled Study.
Lead sponsor
Ospedale Policlinico San Martino
Phase
Not applicable
Overall status
Recruiting
Start date
September 2, 2024
Completion date
January 31, 2026
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, multiple sclerosis